Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Genetic Variants Within Molecular Targets of Antipsychotic Treatment: Effects on Treatment Response, Schizophrenia Risk, and Psychopathological Features.

Calabrò M, Porcelli S, Crisafulli C, Wang SM, Lee SJ, Han C, Patkar AA, Masand PS, Albani D, Raimondi I, Forloni G, Bin S, Cristalli C, Mantovani V, Pae CU, Serretti A.

J Mol Neurosci. 2018 Jan;64(1):62-74. doi: 10.1007/s12031-017-1002-1. Epub 2017 Nov 21.

PMID:
29164477
2.

Genetic Variants Within Key Nodes of the Cascade of Antipsychotic Mechanisms: Effects on Antipsychotic Response and Schizophrenia Psychopathology in a Naturalistic Treatment Setting in Two Independent Korean and Italian Samples.

Calabrò M, Porcelli S, Crisafulli C, Wang SM, Lee SJ, Han C, Patkar AA, Masand PS, Albani D, Raimondi I, Forloni G, Bin S, Mattiaccio A, Mantovani V, Jun TY, Pae CU, Serretti A.

Adv Ther. 2017 Jun;34(6):1482-1497. doi: 10.1007/s12325-017-0555-2. Epub 2017 May 16.

PMID:
28508933
3.

Case-control association study for 10 genes in patients with schizophrenia: influence of 5HTR1A variation rs10042486 on schizophrenia and response to antipsychotics.

Crisafulli C, Chiesa A, Han C, Lee SJ, Park MH, Balzarro B, Andrisano C, Patkar AA, Pae CU, Serretti A.

Eur Arch Psychiatry Clin Neurosci. 2012 Apr;262(3):199-205. doi: 10.1007/s00406-011-0278-3. Epub 2011 Nov 27.

PMID:
22120873
4.

CACNA1C gene and schizophrenia: a case-control and pharmacogenetic study.

Porcelli S, Lee SJ, Han C, Patkar AA, Serretti A, Pae CU.

Psychiatr Genet. 2015 Aug;25(4):163-7. doi: 10.1097/YPG.0000000000000092.

PMID:
26049408
5.

The influence of AHI1 variants on the diagnosis and treatment outcome in schizophrenia.

Porcelli S, Pae CU, Han C, Lee SJ, Patkar AA, Masand PS, Balzarro B, Alberti S, De Ronchi D, Serretti A.

Int J Mol Sci. 2015 Jan 22;16(2):2517-29. doi: 10.3390/ijms16022517.

6.

Hot Genes in Schizophrenia: How Clinical Datasets Could Help to Refine their Role.

Porcelli S, Lee SJ, Han C, Patkar AA, Albani D, Jun TY, Pae CU, Serretti A.

J Mol Neurosci. 2018 Feb;64(2):273-286. doi: 10.1007/s12031-017-1016-8. Epub 2017 Dec 19.

PMID:
29260453
7.

Catechol-O-methyltransferase gene variants may associate with negative symptom response and plasma concentrations of prolactin in schizophrenia after amisulpride treatment.

Chen CY, Yeh YW, Kuo SC, Ho PS, Liang CS, Yen CH, Lu RB, Huang SY.

Psychoneuroendocrinology. 2016 Mar;65:67-75. doi: 10.1016/j.psyneuen.2015.12.003. Epub 2015 Dec 8.

PMID:
26724569
8.

DRD2 co-expression network and a related polygenic index predict imaging, behavioral and clinical phenotypes linked to schizophrenia.

Pergola G, Di Carlo P, D'Ambrosio E, Gelao B, Fazio L, Papalino M, Monda A, Scozia G, Pietrangelo B, Attrotto M, Apud JA, Chen Q, Mattay VS, Rampino A, Caforio G, Weinberger DR, Blasi G, Bertolino A.

Transl Psychiatry. 2017 Jan 17;7(1):e1006. doi: 10.1038/tp.2016.253.

9.

PDE7B, NMBR and EPM2A Variants and Schizophrenia: A Case-Control and Pharmacogenetics Study.

Porcelli S, Balzarro B, Lee SJ, Han C, Patkar AA, Pae CU, Serretti A.

Neuropsychobiology. 2016;73(3):160-8. doi: 10.1159/000445295. Epub 2016 Apr 20.

PMID:
27092952
10.

Genetic predictors of antipsychotic response to lurasidone identified in a genome wide association study and by schizophrenia risk genes.

Li J, Yoshikawa A, Brennan MD, Ramsey TL, Meltzer HY.

Schizophr Res. 2018 Feb;192:194-204. doi: 10.1016/j.schres.2017.04.009. Epub 2017 Apr 19.

PMID:
28431800
11.

Genetic risk factors for type 2 diabetes with pharmacologic intervention in African-American patients with schizophrenia or schizoaffective disorder.

Irvin MR, Wiener HW, Perry RP, Savage RM, Go RC.

Schizophr Res. 2009 Oct;114(1-3):50-6. doi: 10.1016/j.schres.2009.07.008. Epub 2009 Jul 29.

12.

Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain.

Kaalund SS, Newburn EN, Ye T, Tao R, Li C, Deep-Soboslay A, Herman MM, Hyde TM, Weinberger DR, Lipska BK, Kleinman JE.

Mol Psychiatry. 2014 Dec;19(12):1258-66. doi: 10.1038/mp.2013.165. Epub 2013 Dec 10.

PMID:
24322206
13.

Influence of 5-HT3 receptor subunit genes HTR3A, HTR3B, HTR3C, HTR3D and HTR3E on treatment response to antipsychotics in schizophrenia.

Schuhmacher A, Mössner R, Quednow BB, Kühn KU, Wagner M, Cvetanovska G, Rujescu D, Zill P, Möller HJ, Rietschel M, Franke P, Wölwer W, Gaebel W, Maier W.

Pharmacogenet Genomics. 2009 Nov;19(11):843-51. doi: 10.1097/FPC.0b013e3283313296.

PMID:
19794330
14.

Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone.

Yamanouchi Y, Iwata N, Suzuki T, Kitajima T, Ikeda M, Ozaki N.

Pharmacogenomics J. 2003;3(6):356-61.

PMID:
14610521
15.

Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach.

Ruderfer DM, Charney AW, Readhead B, Kidd BA, Kähler AK, Kenny PJ, Keiser MJ, Moran JL, Hultman CM, Scott SA, Sullivan PF, Purcell SM, Dudley JT, Sklar P.

Lancet Psychiatry. 2016 Apr;3(4):350-7. doi: 10.1016/S2215-0366(15)00553-2. Epub 2016 Feb 23.

16.

Association study of polymorphisms in the alpha 7 nicotinic acetylcholine receptor subunit and catechol-o-methyl transferase genes with sensory gating in first-episode schizophrenia.

Liu X, Hong X, Chan RC, Kong F, Peng Z, Wan X, Wang C, Cheng L.

Psychiatry Res. 2013 Oct 30;209(3):431-8. doi: 10.1016/j.psychres.2013.03.027. Epub 2013 Apr 15.

PMID:
23598060
17.

Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia.

Campbell DB, Ebert PJ, Skelly T, Stroup TS, Lieberman J, Levitt P, Sullivan PF.

Biol Psychiatry. 2008 Jan 1;63(1):32-41. Epub 2007 Jun 22.

18.

Genetic association analysis of ITGB3 polymorphisms with age at onset of schizophrenia.

Wang KS, Liu X, Arana TB, Thompson N, Weisman H, Devargas C, Mao C, Su BB, Camarillo C, Escamilla MA, Xu C.

J Mol Neurosci. 2013 Oct;51(2):446-53. doi: 10.1007/s12031-013-0059-8. Epub 2013 Jul 17.

PMID:
23860687
19.

Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics.

Qi LY, Xiu MH, Chen DC, Wang F, Kosten TA, Kosten TR, Zhang XY.

Neurosci Lett. 2009 Sep 22;462(2):113-7. doi: 10.1016/j.neulet.2009.06.019. Epub 2009 Jun 17.

PMID:
19539717
20.

Association analysis of CHRNA3 polymorphisms with schizophrenia in a Chinese Han population: A case-control study.

Li G, Bai M, Guo C, Zhu L, Wang L, Yuan D, Jin T, He Y.

Medicine (Baltimore). 2018 Jun;97(23):e10863. doi: 10.1097/MD.0000000000010863.

Supplemental Content

Support Center